Background: Hydroxyethyl starch (HES) effectively restores plasma volume and thereby enhances microcirculation and tissue oxygenation at the expense of coagulation impairment. These effects are related to molecular weight, substitution and C2：C6 ratio. But, most of the studies regarding coagulation impairment in cardiac surgeries were performed in patients undergoing cardiopulmonary bypass which significantly causes coagulation derangements. Therefore, we have evaluated the effects of 2 different HES solutions on tissue oxygenation and postoperative bleeding in patients undergoing off-pump coronary artery bypass surgery (OPCAB).
CI (L/min/m 2 ) H 3 . 0 ± 0.7 2.8 ± 0.6 2.7 ± 0.7 3.2 ± 0.7 3.4 ± 0.6 V 3 . 1 ± 0.6 2.5 ± 0.4 2.7 ± 0.5 3.5 ± 0.9 3.6 ± 0.5 DO2 (ml/ Values are mean ± SD. T1: after induction of anesthesia, T2: at the end of anastomosis, T3: end of surgery, T4: at the admission at intensive care unit (ICU), T5: 4 hr after admission at ICU, H: 6% hydroxyethyl starch 200/0.5, V: 6% hydroxyethyl starch 130/0.4, CI: cardiac index, DO2: oxygen delivery, VO2: oxygen consumption; BE: base excess, SvO2: mixed venous oxygen saturation, P/F ratio: ratio of arterial oxygen tension to inspired oxygen fraction, RSCdyn: dynamic respiratory system compliance, RSCstat: static respiratory system compliance, Hct: hematocrite. There were no significant differences between groups.
차이가 없었다. 수술 중과 중환자실에서 수혈된 농축적혈구 량(H군 339 ± 368 ml, V군 109 ± 215 ml, P = 0. 
